Profiles

Keywords
Last Name
Institution

Gary Chmielewski

Concepts (238)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
20
2020
756
1.830
Why?
Carcinoma, Non-Small-Cell Lung
11
2017
374
1.090
Why?
Thoracotomy
4
2016
34
0.920
Why?
Pneumonectomy
5
2020
90
0.820
Why?
Esophageal Neoplasms
3
2015
61
0.710
Why?
Thoracic Surgery, Video-Assisted
3
2020
22
0.670
Why?
Unnecessary Procedures
2
2019
30
0.620
Why?
Adenocarcinoma
7
2015
237
0.620
Why?
Esophagectomy
2
2011
25
0.560
Why?
Barrett Esophagus
4
2015
19
0.560
Why?
Catheter Ablation
4
2015
76
0.520
Why?
Esophageal Diseases
1
2011
7
0.460
Why?
Jejunostomy
1
2011
8
0.450
Why?
Enteral Nutrition
1
2011
64
0.430
Why?
Abnormalities, Drug-Induced
4
2016
9
0.420
Why?
Aged
26
2019
10295
0.410
Why?
Neoplasm Recurrence, Local
3
2017
236
0.400
Why?
Empyema, Pleural
1
2009
1
0.390
Why?
Negative-Pressure Wound Therapy
1
2009
5
0.390
Why?
Neoplasm Staging
12
2019
481
0.380
Why?
Intraoperative Complications
1
2009
76
0.370
Why?
Echinocandins
3
2012
7
0.350
Why?
Positron-Emission Tomography
3
2011
95
0.350
Why?
Male
29
2019
17583
0.340
Why?
Surgical Wound Infection
1
2009
106
0.340
Why?
Drainage
2
2009
55
0.340
Why?
Toxicity Tests
4
2016
9
0.330
Why?
Female
30
2019
18253
0.330
Why?
Postoperative Complications
4
2016
1083
0.320
Why?
Embryonic Development
3
2016
8
0.310
Why?
Retrospective Studies
11
2017
3591
0.290
Why?
Embryo, Mammalian
2
2016
36
0.280
Why?
Humans
32
2020
31481
0.270
Why?
Solitary Pulmonary Nodule
2
2015
14
0.270
Why?
Middle Aged
20
2017
11209
0.260
Why?
Carcinoma, Squamous Cell
2
2019
207
0.260
Why?
Bronchoscopy
3
2019
38
0.260
Why?
Pleurodesis
1
2003
2
0.260
Why?
Pleural Effusion, Malignant
1
2003
6
0.250
Why?
Consensus
2
2020
106
0.240
Why?
Prognosis
6
2017
1028
0.230
Why?
Radiosurgery
3
2011
43
0.230
Why?
Antifungal Agents
2
2012
42
0.220
Why?
Aged, 80 and over
12
2017
5234
0.220
Why?
Treatment Outcome
11
2017
3910
0.220
Why?
Survival Analysis
5
2017
379
0.210
Why?
Education, Medical, Graduate
1
2020
83
0.200
Why?
Small Cell Lung Carcinoma
1
2019
13
0.190
Why?
False Positive Reactions
1
2019
40
0.190
Why?
Surgeons
1
2020
84
0.190
Why?
Fetal Development
2
2016
7
0.190
Why?
Computer Simulation
1
2020
249
0.190
Why?
Cohort Studies
4
2017
2014
0.190
Why?
Fetus
2
2016
63
0.180
Why?
Registries
4
2015
214
0.180
Why?
Bone and Bones
2
2016
110
0.170
Why?
Neovascularization, Pathologic
2
2015
68
0.170
Why?
Tracheomalacia
1
2017
5
0.170
Why?
Tracheal Stenosis
1
2017
8
0.170
Why?
Silicones
1
2017
14
0.170
Why?
Airway Obstruction
1
2017
21
0.170
Why?
Multivariate Analysis
5
2017
390
0.170
Why?
Length of Stay
3
2016
377
0.170
Why?
Mutagenicity Tests
1
2016
1
0.170
Why?
Hazardous Substances
1
2016
2
0.170
Why?
Teratogens
1
2016
2
0.170
Why?
Clinical Competence
2
2020
274
0.160
Why?
Insulin-Like Growth Factor I
2
2014
60
0.160
Why?
Risk Assessment
4
2017
806
0.160
Why?
Pharmaceutical Preparations
1
2016
24
0.160
Why?
Developmental Biology
1
2016
1
0.160
Why?
Models, Animal
1
2016
149
0.160
Why?
Thoracic Wall
1
2016
12
0.160
Why?
Ribs
1
2016
19
0.160
Why?
Metformin
1
2016
21
0.160
Why?
Sensitivity and Specificity
2
2009
580
0.150
Why?
Stents
1
2017
155
0.150
Why?
X-Ray Microtomography
1
2016
71
0.150
Why?
Disease Progression
4
2014
861
0.150
Why?
Esophagoscopy
1
2015
18
0.150
Why?
Learning Curve
1
2015
19
0.150
Why?
Hypoglycemic Agents
1
2016
76
0.150
Why?
Thoracoscopy
2
2019
20
0.150
Why?
Insulin-Like Growth Factor II
1
2014
10
0.140
Why?
Insulin-Like Growth Factor Binding Proteins
1
2014
15
0.140
Why?
Rats
5
2016
966
0.140
Why?
Tumor Burden
3
2010
42
0.140
Why?
Cytokines
2
2014
364
0.140
Why?
Intubation, Intratracheal
2
2016
70
0.130
Why?
Animals
8
2016
5312
0.130
Why?
Kaplan-Meier Estimate
2
2015
230
0.130
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
11
0.130
Why?
Multiple Pulmonary Nodules
1
2013
9
0.130
Why?
Diabetes Mellitus, Type 2
1
2016
224
0.120
Why?
Prosthesis Failure
1
2017
534
0.120
Why?
Fundoplication
1
2012
24
0.120
Why?
Immunoassay
1
2012
45
0.120
Why?
Research Design
2
2012
238
0.120
Why?
Gastroesophageal Reflux
1
2012
35
0.120
Why?
Nitriles
1
2012
17
0.120
Why?
Pyrimidines
1
2012
31
0.120
Why?
Diagnosis, Differential
2
2015
467
0.120
Why?
Triazoles
1
2012
32
0.120
Why?
Predictive Value of Tests
4
2016
637
0.120
Why?
Gastric Fistula
1
2011
4
0.110
Why?
Fistula
1
2011
6
0.110
Why?
Disease-Free Survival
3
2017
241
0.110
Why?
Dose-Response Relationship, Drug
4
2016
512
0.110
Why?
Nutrition Assessment
1
2011
53
0.110
Why?
Hospitals, Community
1
2011
21
0.110
Why?
Community-Institutional Relations
1
2011
15
0.110
Why?
Pyrazoles
1
2012
55
0.110
Why?
Radiography, Interventional
1
2011
29
0.110
Why?
Anticarcinogenic Agents
1
2010
18
0.110
Why?
Medical Oncology
1
2011
39
0.110
Why?
Receptor, IGF Type 1
1
2010
21
0.110
Why?
Tomography, X-Ray Computed
5
2015
891
0.110
Why?
Algorithms
3
2014
412
0.110
Why?
Minority Groups
1
2011
79
0.100
Why?
Behavior, Animal
1
2011
113
0.100
Why?
Bronchi
1
2010
19
0.100
Why?
Adult
8
2017
9779
0.100
Why?
Prospective Studies
5
2015
1934
0.100
Why?
Trachea
1
2010
23
0.100
Why?
Heart Diseases
1
2011
102
0.100
Why?
Thoracic Surgical Procedures
1
2009
12
0.100
Why?
Probability
1
2009
104
0.100
Why?
Age Factors
2
2009
943
0.100
Why?
Risk Factors
5
2015
2664
0.100
Why?
Thoracic Surgery
1
2009
33
0.100
Why?
Patient Selection
1
2011
264
0.100
Why?
Statistics, Nonparametric
1
2009
156
0.100
Why?
Area Under Curve
3
2014
79
0.100
Why?
Clinical Trials as Topic
1
2011
378
0.090
Why?
Antibodies, Monoclonal
1
2010
301
0.090
Why?
Staphylococcus aureus
1
2009
87
0.090
Why?
Survival Rate
2
2010
465
0.090
Why?
Body Mass Index
1
2011
458
0.090
Why?
Recurrence
2
2014
389
0.090
Why?
Rats, Inbred F344
3
2012
51
0.090
Why?
Neoplasms
1
2011
280
0.090
Why?
Laparoscopy
1
2009
190
0.080
Why?
United States
4
2015
2539
0.080
Why?
Staphylococcal Infections
1
2009
176
0.080
Why?
Neoplasm Invasiveness
2
2017
104
0.080
Why?
Lung
2
2005
171
0.080
Why?
Rabbits
2
2016
326
0.080
Why?
Pneumonia
2
2019
74
0.070
Why?
Pregnancy
3
2012
457
0.070
Why?
Protein-Lysine 6-Oxidase
1
2005
1
0.070
Why?
Carcinoma, Bronchogenic
1
2005
14
0.070
Why?
Minimally Invasive Surgical Procedures
1
2009
300
0.070
Why?
Time Factors
3
2015
1902
0.070
Why?
Logistic Models
2
2015
479
0.070
Why?
ROC Curve
2
2014
153
0.060
Why?
Catheters, Indwelling
1
2003
30
0.060
Why?
Follow-Up Studies
3
2014
2028
0.060
Why?
Proton Pump Inhibitors
2
2012
15
0.060
Why?
Reproducibility of Results
2
2016
886
0.060
Why?
Incidence
2
2015
829
0.060
Why?
Brain
1
2011
1655
0.050
Why?
Mediastinoscopy
1
2019
5
0.050
Why?
Sex Factors
2
2012
542
0.050
Why?
Reoperation
2
2015
938
0.050
Why?
Early Detection of Cancer
1
2019
91
0.040
Why?
Radiography
2
2013
717
0.040
Why?
Dilatation
1
2017
13
0.040
Why?
Pulmonary Diffusing Capacity
1
2016
10
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2016
34
0.040
Why?
Pneumonia, Bacterial
1
2016
15
0.040
Why?
Young Adult
2
2014
2277
0.040
Why?
Tracheostomy
1
2016
28
0.040
Why?
Protective Factors
1
2015
19
0.040
Why?
Observer Variation
1
2016
146
0.040
Why?
Chemoradiotherapy, Adjuvant
1
2015
21
0.040
Why?
Least-Squares Analysis
1
2015
9
0.040
Why?
Hospitals, Low-Volume
1
2015
7
0.040
Why?
Hospitals, High-Volume
1
2015
10
0.040
Why?
Guidelines as Topic
1
2016
79
0.040
Why?
Remission Induction
1
2015
119
0.040
Why?
Cause of Death
1
2015
78
0.040
Why?
Databases, Factual
1
2017
391
0.040
Why?
Chi-Square Distribution
1
2015
178
0.040
Why?
Minnesota
1
2014
12
0.040
Why?
Proportional Hazards Models
1
2016
390
0.040
Why?
Diabetes Mellitus
1
2016
150
0.040
Why?
Linear Models
1
2015
276
0.030
Why?
Odds Ratio
1
2015
327
0.030
Why?
Illinois
1
2014
266
0.030
Why?
Chemokine CCL3
1
2013
14
0.030
Why?
Granuloma
1
2013
16
0.030
Why?
Interleukin 1 Receptor Antagonist Protein
1
2013
16
0.030
Why?
Chemokine CXCL12
1
2013
9
0.030
Why?
Respiratory Tract Infections
1
2013
25
0.030
Why?
Interleukin-10
1
2013
42
0.030
Why?
Maternal Exposure
1
2012
1
0.030
Why?
Interleukin-6
1
2013
120
0.030
Why?
Decision Support Techniques
1
2012
55
0.030
Why?
Voriconazole
1
2012
7
0.030
Why?
Injections, Subcutaneous
1
2012
41
0.030
Why?
Lymphatic Metastasis
1
2012
107
0.030
Why?
Tissue Distribution
1
2012
50
0.030
Why?
Drug Evaluation, Preclinical
1
2012
39
0.030
Why?
Animals, Newborn
1
2012
77
0.030
Why?
Cesarean Section
1
2012
33
0.030
Why?
Drug Combinations
1
2012
88
0.030
Why?
Hematemesis
1
2011
2
0.030
Why?
Stomach Ulcer
1
2011
5
0.030
Why?
Tumor Necrosis Factor-alpha
1
2013
230
0.030
Why?
Esophageal Perforation
1
2011
10
0.030
Why?
Administration, Oral
1
2012
164
0.030
Why?
Osteogenesis
1
2012
94
0.030
Why?
Candidiasis
1
2011
23
0.030
Why?
Fatal Outcome
1
2011
75
0.030
Why?
Gastrointestinal Hemorrhage
1
2011
29
0.030
Why?
Body Weight
1
2012
167
0.030
Why?
Michigan
1
2011
21
0.030
Why?
Sex Distribution
1
2011
89
0.030
Why?
Feeding Behavior
1
2012
122
0.030
Why?
Radiopharmaceuticals
1
2011
63
0.030
Why?
Organogenesis
1
2010
2
0.030
Why?
Maternal-Fetal Exchange
1
2010
11
0.030
Why?
Macaca fascicularis
1
2010
28
0.030
Why?
Immunoglobulins, Intravenous
1
2010
25
0.030
Why?
Program Evaluation
1
2011
153
0.030
Why?
Contrast Media
1
2011
144
0.030
Why?
Healthcare Disparities
1
2011
82
0.030
Why?
Rupture
1
2010
115
0.030
Why?
Hospitalization
1
2012
359
0.020
Why?
Comorbidity
1
2011
562
0.020
Why?
Motor Activity
1
2011
397
0.020
Why?
Radiotherapy Dosage
1
2007
149
0.020
Why?
Radiotherapy Planning, Computer-Assisted
1
2007
78
0.020
Why?
Mice
1
2012
1894
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
191
0.020
Why?
RNA, Messenger
1
2005
371
0.020
Why?
Cognition
1
2011
1206
0.020
Why?
Aging
1
2012
1614
0.010
Why?
Chmielewski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description